OBJECTIVE: To examine the maintenance of effects of Motivational Enhancement Therapy (MET) shown to improve risk behaviors and viral load in youth living with HIV (YLH) immediately posttreatment. METHODS:Sixty-five youth (ages 16-25 years) were randomized to Healthy Choices or a waitlist control. Frequency of substance use, frequency of unprotected intercourse, and viral load were obtained at baseline, 3, and 6 months after study entry. The waitlist control then received intervention. An additional data collection was obtained at 9 months for follow-up of the original treatment group. RESULTS: One-tailed ANOVA showed that the treatment group had greater reductions in viral load and alcohol use from baseline to 6 months. These reductions appeared to be maintained at 9-month follow-up. Improvements in sexual risk were not evident. CONCLUSIONS: MET showed significant promise in reducing substance use and in improving HIV-related health in YLH immediately posttreatment. These effects were maintained after treatment termination.
RCT Entities:
OBJECTIVE: To examine the maintenance of effects of Motivational Enhancement Therapy (MET) shown to improve risk behaviors and viral load in youth living with HIV (YLH) immediately posttreatment. METHODS: Sixty-five youth (ages 16-25 years) were randomized to Healthy Choices or a waitlist control. Frequency of substance use, frequency of unprotected intercourse, and viral load were obtained at baseline, 3, and 6 months after study entry. The waitlist control then received intervention. An additional data collection was obtained at 9 months for follow-up of the original treatment group. RESULTS: One-tailed ANOVA showed that the treatment group had greater reductions in viral load and alcohol use from baseline to 6 months. These reductions appeared to be maintained at 9-month follow-up. Improvements in sexual risk were not evident. CONCLUSIONS: MET showed significant promise in reducing substance use and in improving HIV-related health in YLH immediately posttreatment. These effects were maintained after treatment termination.
Authors: Jennifer L Brown; Kelly S DeMartini; Jessica M Sales; Andrea L Swartzendruber; Ralph J DiClemente Journal: Curr HIV/AIDS Rep Date: 2013-12 Impact factor: 5.071
Authors: Sylvie Naar-King; Jeffrey T Parsons; Debra A Murphy; Xinguang Chen; D Robert Harris; Marvin E Belzer Journal: Arch Pediatr Adolesc Med Date: 2009-12
Authors: Hannah Wolfe; Deborah L Haller; Ellen Benoit; Kelly W Bolger; James C Cancienne; Karen S Ingersoll; Victoria Sharp Journal: AIDS Care Date: 2012-12-12
Authors: Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell Journal: AIDS Behav Date: 2014-04
Authors: Jeannie S Huang; Sarah E Barlow; Ruben E Quiros-Tejeira; Ann Scheimann; Joseph Skelton; David Suskind; Patrika Tsai; Victor Uko; Joshua P Warolin; Stavra A Xanthakos Journal: J Pediatr Gastroenterol Nutr Date: 2013-01 Impact factor: 2.839